Cardinal Health (CAH)

Cost of Revenue

$244.47B

TTM · Period ending: · USD

CAH logo

CAH Cost of Revenue

Latest reported$244.47B
CAH TTM Cost of Revenue ($0.00 → $244.47B)
High-resolution chart · PNG

CAH cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cardinal Health Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
244,474,000,000
241,319,000,000
235,632,000,000
225,725,000,000
214,410,000,000
214,308,000,000
214,486,000,000
216,751,000,000
219,283,000,000
213,054,000,000
208,823,000,000
203,041,000,000
198,123,000,000
191,995,000,000
186,447,000,000
180,482,000,000
174,819,000,000
170,432,000,000
164,741,000,000
160,665,000,000
155,689,000,000
149,677,000,000
149,486,000,000
147,742,000,000
146,054,000,000
146,634,000,000
142,826,000,000
140,815,000,000
138,699,000,000
136,634,000,000
134,890,000,000
132,205,000,000
129,628,000,000
127,357,000,000
125,730,000,000
123,953,000,000
123,433,000,000
121,808,000,000
120,688,000,000
118,976,000,000
115,003,000,000
111,375,000,000
106,318,000,000
100,565,000,000
96,818,000,000
92,366,000,000
88,580,000,000
85,392,000,000
85,922,000,000
88,456,000,000
91,587,000,000
94,700,000,000
96,171,000,000
97,627,500,000
100,077,500,000
102,033,500,000
103,011,500,000
103,103,200,000
102,301,400,000
100,715,000,000
98,482,300,000
96,317,600,000
94,741,100,000
94,325,500,000
94,722,100,000
94,949,800,000
94,719,500,000
93,960,200,000
92,624,200,000
90,297,200,000
88,636,600,000
87,362,000,000
85,457,300,000
84,906,500,000
83,944,300,000
82,500,900,000
81,606,700,000
80,982,200,000
79,461,400,000
77,157,900,000
75,463,900,000
73,273,400,000
71,945,300,000
71,112,200,000
69,771,000,000
67,396,200,000
64,873,900,000
62,715,600,000
60,319,300,000
58,562,800,000
56,631,600,000
54,453,300,000
52,227,000,000
50,233,600,000
49,229,900,000
48,310,000,000
47,089,500,000
46,548,900,000
43,763,500,000
40,500,800,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.